4553 Stock Overview
Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Towa Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,811.00 |
| 52 Week High | JP¥3,240.00 |
| 52 Week Low | JP¥2,223.00 |
| Beta | 0.010 |
| 11 Month Change | -7.38% |
| 3 Month Change | -0.21% |
| 1 Year Change | 3.35% |
| 33 Year Change | -6.77% |
| 5 Year Change | 20.85% |
| Change since IPO | 22.35% |
Recent News & Updates
Towa Pharmaceutical (TSE:4553) Is Due To Pay A Dividend Of ¥30.00
Aug 15
Fewer Investors Than Expected Jumping On Towa Pharmaceutical Co., Ltd. (TSE:4553)
Aug 03Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem
Jul 03Shareholder Returns
| 4553 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.3% | 5.5% | 4.6% |
| 1Y | 3.3% | 19.1% | 15.9% |
Return vs Industry: 4553 underperformed the JP Pharmaceuticals industry which returned 19.1% over the past year.
Return vs Market: 4553 underperformed the JP Market which returned 15.9% over the past year.
Price Volatility
| 4553 volatility | |
|---|---|
| 4553 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.0% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 4553 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4553's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 4,588 | Itsuro Yoshida | www.towayakuhin.co.jp |
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services.
Towa Pharmaceutical Co., Ltd. Fundamentals Summary
| 4553 fundamental statistics | |
|---|---|
| Market cap | JP¥138.36b |
| Earnings (TTM) | JP¥16.92b |
| Revenue (TTM) | JP¥235.95b |
8.2x
P/E Ratio0.6x
P/S RatioIs 4553 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4553 income statement (TTM) | |
|---|---|
| Revenue | JP¥235.95b |
| Cost of Revenue | JP¥151.24b |
| Gross Profit | JP¥84.72b |
| Other Expenses | JP¥67.80b |
| Earnings | JP¥16.92b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 343.72 |
| Gross Margin | 35.90% |
| Net Profit Margin | 7.17% |
| Debt/Equity Ratio | 130.8% |
How did 4553 perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield17%
Payout RatioDoes 4553 pay a reliable dividends?
See 4553 dividend history and benchmarks| Towa Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 36 days |
| Days until Dividend pay date | 102 days |
Does 4553 pay a reliable dividends?
See 4553 dividend history and benchmarks